NCT07100418View on ClinicalTrials.gov

A Clinical Study Evaluating the Efficacy and Safety of HRS-7249 in Treating Patients With Hyperlipidemia

PHASE2RecruitingINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

August 12, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

January 31, 2027

Conditions

Hyperlipidemia

Interventions

DRUG

HRS-7249 Injection

HRS-7249 injection.

DRUG

Sodium Chloride Injection

Sodium chloride injection.

Trial Locations (1)

200030

RECRUITING

Shanghai Chest Hospital, Shanghai

All Listed Sponsors

lead

Fujian Shengdi Pharmaceutical Co., Ltd.

INDUSTRY

NCT07100418 - A Clinical Study Evaluating the Efficacy and Safety of HRS-7249 in Treating Patients With Hyperlipidemia | Biotech Hunter | Biotech Hunter